T-cell Modulating Therapy
T-Cell Modulating Therapy is a pharmacotherapeutic strategy within neuroinflammatory disorder treatment that selectively alters T-cell activation, proliferation, or function to restore immune homeostasis and mitigate central nervous system inflammation.
32
Publications
1.7K
Citations
232
Authors
109
Institutions
Publications per year
2017–2026
11
32
Rina Aharoni, Başak Kayhan, Raya Eilam et al. · Proceedings of the National Academy of Sciences · 2003 · 232 citations · Full text
T cell factor which can replace T cells in vivo
Michael Taussig · Nature · 1974 · 156 citations
1–5 of 32
232
1
h-index
1
h-index
1
h-index
1
h-index
The University of Texas Medical Branch at Galveston, United States
1 publications · 22 citations
1
h-index
1–5 of 232
109
The University of Texas MD Anderson Cancer Center
Houston, United States
3 h-index
13 publications
378 citations
Moffitt Cancer Center
Tampa, United States
2 h-index
2 publications
34 citations
Catholic University of Korea
Seoul, South Korea
1 h-index
1 publications
16 citations
Wuhan University
Wuhan, China
1 h-index
8 publications
160 citations
Harvard University
Cambridge, United States
1 h-index
1 publications
10 citations
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
1 h-index
1 publications
16 citations
First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
1 h-index
9 publications
198 citations

Huazhong University of Science and Technology
Wuhan, China
1 h-index
3 publications
57 citations
1–8 of 109
PNAS · 2 publications · 264 citations
2
h-index
JNI · 2 publications · 145 citations
2
h-index
2 publications · 118 citations
2
h-index
2 publications · 218 citations
2
h-index
2 publications · 73 citations
2
h-index
1–5